Evidence map›Paper›PMID 25386896›Full record

ArticlePloS one2014

CD148 tyrosine phosphatase promotes cadherin cell adhesion.

Keiko Takahashi, Anton Matafonov, Katherine Sumarriva, Hideyuki Ito, Colette Lauhan, Dana Zemel, Nobuo Tsuboi, Jin Chen, Albert Reynolds, Takamune Takahashi

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Agonistic anti-CD148 monoclonal antibody attenuates diabetic nephropathy in mice.American journal of physiology. Renal physiology · 2020
    Article
  9. Review
  10. Adherens Junction and E-Cadherin complex regulation by epithelial polarity.Cellular and molecular life sciences : CMLS · 2016
    Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Keiko TakahashiDepartment of Medicine, Vanderbilt University School of Medicine, Nashville, TN, United States of America.
Anton MatafonovDepartment of Medicine, Vanderbilt University School of Medicine, Nashville, TN, United States of America.
Katherine SumarrivaDepartment of Medicine, Vanderbilt University School of Medicine, Nashville, TN, United States of America.
Hideyuki ItoDepartment of Medicine, Vanderbilt University School of Medicine, Nashville, TN, United States of America.
Colette LauhanDepartment of Medicine, Vanderbilt University School of Medicine, Nashville, TN, United States of America.
Dana ZemelDepartment of Medicine, Vanderbilt University School of Medicine, Nashville, TN, United States of America.
Nobuo TsuboiDepartment of Medicine, Vanderbilt University School of Medicine, Nashville, TN, United States of America.
Jin ChenDepartment of Medicine, Vanderbilt University School of Medicine, Nashville, TN, United States of America; Department of Cancer Biology, Vanderbilt University School of Medicine, Nashville, TN, United States of America.
Albert ReynoldsDepartment of Cancer Biology, Vanderbilt University School of Medicine, Nashville, TN, United States of America.
Takamune TakahashiDepartment of Medicine, Vanderbilt University School of Medicine, Nashville, TN, United States of America; Department of Cancer Biology, Vanderbilt University School of Medicine, Nashville, TN, United States of America.
Vanderbilt University · US

Funding

Vanderbilt Diabetes Research CenterP30DK020593 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI ALVIN C POWERS · 2012 to 2026
$29.3M
TYROSINE PHOSPHATASES IN ENDOTHELIAL GROWTH CONTROLR01DK038517 · NIDDK · VANDERBILT UNIVERSITY · PI TAKAHASHI, TAKAMUNE · 1987 to 2009
$2.8M
ephrin-A1 in lipogenesis and breast cancer metastatic progressionR01CA177681 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BRANTLEY-SIEDERS, DANA M, CHEN, JIN · 2014 to 2019
$1.9M
Role of CD148 Tyrosine Phosphatase in Diabetic NephropathyR01DK097332 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI TAKAHASHI, TAKAMUNE · 2012 to 2016
$1.7M
Role of CD148 Tyrosine Phosphatase in AngiogenesisR21HL109715 · NHLBI · VANDERBILT UNIVERSITY · PI TAKAHASHI, TAKAMUNE · 2013 to 2014
$424k
NCI NIH HHS R01 CA177681NHLBI NIH HHS HL109715NHLBI NIH HHS R21 HL109715NIDDK NIH HHS DK38517NIDDK NIH HHS DK97332NIDDK NIH HHS P30 DK020593NIDDK NIH HHS R01 DK038517NIDDK NIH HHS R01 DK097332
6 · The paper itself

Abstract

CD148 is a transmembrane tyrosine phosphatase that is expressed at cell junctions. Recent studies have shown that CD148 associates with the cadherin/catenin complex and p120 catenin (p120) may serve as a substrate. However, the role of CD148 in cadherin cell-cell adhesion remains unknown. Therefore, here we addressed this issue using a series of stable cells and cell-based assays. Wild-type (WT) and catalytically inactive (CS) CD148 were introduced to A431D (lacking classical cadherins), A431D/E-cadherin WT (expressing wild-type E-cadherin), and A431D/E-cadherin 764AAA (expressing p120-uncoupled E-cadherin mutant) cells. The effects of CD148 in cadherin adhesion were assessed by Ca2+ switch and cell aggregation assays. Phosphorylation of E-cadherin/catenin complex and Rho family GTPase activities were also examined. Although CD148 introduction did not alter the expression levels and complex formation of E-cadherin, p120, and β-catenin, CD148 WT, but not CS, promoted cadherin contacts and strengthened cell-cell adhesion in A431D/E-cadherin WT cells. This effect was accompanied by an increase in Rac1, but not RhoA and Cdc42, activity and largely diminished by Rac1 inhibition. Further, we demonstrate that CD148 reduces the tyrosine phosphorylation of p120 and β-catenin; causes the dephosphorylation of Y529 suppressive tyrosine residue in Src, a well-known CD148 site, increasing Src activity and enhancing the phosphorylation of Y228 (a Src kinase site) in p120, in E-cadherin contacts. Consistent with these findings, CD148 dephosphorylated both p120 and β-catenin in vitro. The shRNA-mediated CD148 knockdown in A431 cells showed opposite effects. CD148 showed no effects in A431D and A431D/E-cadherin 764AAA cells. In aggregate, these findings provide the first evidence that CD148 promotes E-cadherin adhesion by regulating Rac1 activity concomitant with modulation of p120, β-catenin, and Src tyrosine phosphorylation. This effect requires E-cadherin and p120 association.

Indexed as

beta CateninCadherinscdc42 GTP-Binding ProteinCell AdhesionCell LineDrosophila ProteinsHumansPhosphorylationrac GTP-Binding ProteinsReceptor-Like Protein Tyrosine Phosphatases, Class 3rhoA GTP-Binding ProteinTyrosinebeta CateninCadherinscdc42 GTP-Binding ProteinDrosophila ProteinsPTPRJ protein, humanRac1 protein, Drosophilarac GTP-Binding ProteinsReceptor-Like Protein Tyrosine Phosphatases, Class 3rhoA GTP-Binding ProteinRHOA protein, humanTyrosine

Identifiers

PMID25386896
PMCPMC4227875
OpenAlexW1968362548

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.